Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 114

1.

In-vitro stem cell derived red blood cells for transfusion: are we there yet?

Kim HO.

Yonsei Med J. 2014 Mar;55(2):304-9. doi: 10.3349/ymj.2014.55.2.304. Review.

2.

In vitro clinical-grade generation of red blood cells from human umbilical cord blood CD34+ cells.

Baek EJ, Kim HS, Kim S, Jin H, Choi TY, Kim HO.

Transfusion. 2008 Oct;48(10):2235-45. doi: 10.1111/j.1537-2995.2008.01828.x. Epub 2008 Jul 31.

PMID:
18673341
3.

Large-scale production of embryonic red blood cells from human embryonic stem cells.

Olivier EN, Qiu C, Velho M, Hirsch RE, Bouhassira EE.

Exp Hematol. 2006 Dec;34(12):1635-42.

PMID:
17157159
4.

Evaluation of Stem Cell-Derived Red Blood Cells as a Transfusion Product Using a Novel Animal Model.

Shah SN, Gelderman MP, Lewis EM, Farrel J, Wood F, Strader MB, Alayash AI, Vostal JG.

PLoS One. 2016 Dec 13;11(12):e0166657. doi: 10.1371/journal.pone.0166657. eCollection 2016.

5.

Production of erythroid cells from human embryonic stem cells (hESC) and human induced pluripotent stem cells (hiPS).

Anstee DJ.

Transfus Clin Biol. 2010 Sep;17(3):104-9. doi: 10.1016/j.tracli.2010.05.005. Epub 2010 Jul 23.

PMID:
20655785
6.

Stroma-free mass production of clinical-grade red blood cells (RBCs) by using poloxamer 188 as an RBC survival enhancer.

Baek EJ, Kim HS, Kim JH, Kim NJ, Kim HO.

Transfusion. 2009 Nov;49(11):2285-95. doi: 10.1111/j.1537-2995.2009.02303.x. Epub 2009 Jul 10.

PMID:
19602217
7.

Novel, high-yield red blood cell production methods from CD34-positive cells derived from human embryonic stem, yolk sac, fetal liver, cord blood, and peripheral blood.

Olivier E, Qiu C, Bouhassira EE.

Stem Cells Transl Med. 2012 Aug;1(8):604-14. doi: 10.5966/sctm.2012-0059. Epub 2012 Aug 2.

8.

Banking of pluripotent adult stem cells as an unlimited source for red blood cell production: potential applications for alloimmunized patients and rare blood challenges.

Peyrard T, Bardiaux L, Krause C, Kobari L, Lapillonne H, Andreu G, Douay L.

Transfus Med Rev. 2011 Jul;25(3):206-16. doi: 10.1016/j.tmrv.2011.01.002. Epub 2011 Mar 4. Review.

PMID:
21377319
9.

Manufactured RBC--rivers of blood, or an oasis in the desert?

Timmins NE, Nielsen LK.

Biotechnol Adv. 2011 Nov-Dec;29(6):661-6. doi: 10.1016/j.biotechadv.2011.05.002. Epub 2011 May 14. Review.

PMID:
21609758
10.

Concise review: stem cell-derived erythrocytes as upcoming players in blood transfusion.

Zeuner A, Martelli F, Vaglio S, Federici G, Whitsett C, Migliaccio AR.

Stem Cells. 2012 Aug;30(8):1587-96. doi: 10.1002/stem.1136. Review.

11.

From stem cells to red blood cells: how far away from the clinical application?

Xie X, Li Y, Pei X.

Sci China Life Sci. 2014 Jun;57(6):581-5. doi: 10.1007/s11427-014-4667-5. Epub 2014 May 15. Review.

PMID:
24829108
12.

[Red blood cell production for transfusion purposes. A stem cell ex vivo fate].

Mazurier C, Douay L.

Transfus Clin Biol. 2013 May;20(2):90-4. doi: 10.1016/j.tracli.2013.02.020. Epub 2013 Apr 16. Review. French.

PMID:
23601197
13.

Human erythroid cells produced ex vivo at large scale differentiate into red blood cells in vivo.

Neildez-Nguyen TM, Wajcman H, Marden MC, Bensidhoum M, Moncollin V, Giarratana MC, Kobari L, Thierry D, Douay L.

Nat Biotechnol. 2002 May;20(5):467-72.

PMID:
11981559
14.

[In vitro generation of mature and functional human red blood cells: a model with multidisciplinary perspectives].

Douay L, Giarratana MC.

Bull Acad Natl Med. 2005 May;189(5):903-13; discussion 914-5. French.

PMID:
16433462
15.

An in vitro model of human red blood cell production from hematopoietic progenitor cells.

Malik P, Fisher TC, Barsky LL, Zeng L, Izadi P, Hiti AL, Weinberg KI, Coates TD, Meiselman HJ, Kohn DB.

Blood. 1998 Apr 15;91(8):2664-71.

16.

Generation of red blood cells from human embryonic/induced pluripotent stem cells for blood transfusion.

Ebihara Y, Ma F, Tsuji K.

Int J Hematol. 2012 Jun;95(6):610-6. doi: 10.1007/s12185-012-1107-9. Epub 2012 May 31. Review.

PMID:
22648827
17.

Exploring the use of expanded erythroid cells for autologous transfusion for anemia of prematurity.

Khodabux CM, van Hensbergen Y, Slot MC, Bakker-Verweij M, Giordano PC, Brand A.

Transfusion. 2013 Dec;53(12):3230-9. doi: 10.1111/trf.12169. Epub 2013 Mar 22.

PMID:
23521158
18.

Ex-vivo red blood cells generation: a step ahead in transfusion medicine?

Lippi G, Montagnana M, Franchini M.

Eur J Intern Med. 2011 Feb;22(1):16-9. doi: 10.1016/j.ejim.2010.08.001. Epub 2010 Aug 30. Review.

PMID:
21238887
19.

Red blood cells from induced pluripotent stem cells: hurdles and developments.

Mazurier C, Douay L, Lapillonne H.

Curr Opin Hematol. 2011 Jul;18(4):249-53. doi: 10.1097/MOH.0b013e3283476129. Review.

PMID:
21519239
20.

Red blood cell generation from human induced pluripotent stem cells: perspectives for transfusion medicine.

Lapillonne H, Kobari L, Mazurier C, Tropel P, Giarratana MC, Zanella-Cleon I, Kiger L, Wattenhofer-Donzé M, Puccio H, Hebert N, Francina A, Andreu G, Viville S, Douay L.

Haematologica. 2010 Oct;95(10):1651-9. doi: 10.3324/haematol.2010.023556. Epub 2010 May 21.

Supplemental Content

Support Center